Increased TGFβ1 Levels in Children with Localized Scleroderma
Author Information
Author(s): Uziel Yosef, Brian M Feldman, Bernice R Krafchik, Ronald M Laxer, Rae S M Yeung
Primary Institution: The Hospital for Sick Children, Toronto, Canada
Hypothesis
Are serum concentrations of TGFβ1 a good biomarker of disease activity in children with localized scleroderma?
Conclusion
Serum TGFβ1 concentrations are elevated in children with localized scleroderma regardless of disease activity.
Supporting Evidence
- The mean TGFβ1 concentration was significantly higher in the patient group compared to controls.
- TGFβ1 levels did not correlate with disease duration or activity.
- Elevated TGFβ1 levels were found in all subtypes of localized scleroderma.
Takeaway
The study found that kids with a skin condition called localized scleroderma have higher levels of a protein called TGFβ1 in their blood, but this doesn't help doctors know how active the disease is.
Methodology
Serum TGFβ1 levels were measured in 55 pediatric patients with localized scleroderma using ELISA and correlated with disease subtypes and activity.
Potential Biases
Potential bias due to the selection of the control group.
Limitations
The control group consisted of children with atopic dermatitis, which may not accurately represent healthy children.
Participant Demographics
Mean age at disease onset was 9.2 years, with a range from 0.7 to 19.2 years.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website